Has Sarah Burkart, PA received payments from drug or device companies?

Yes. Drug and device makers reported $10,440 in general payments to Sarah Burkart, PA across 240 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Sarah Burkart, PA did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Sarah Burkart, PA come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Sarah Burkart, PA

Physician Assistant · Cincinnati, OHNPI 1396810511

Payments from drug & device makers

$10,440in general payments, 2019–2025

Across 240 payments — averaging $43.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Incyte Corporation$2K
Sun Pharmaceutical Industries Inc.$1K
Dermavant Sciences, Inc.$1K
Ortho Dermatologics, A Division Of Bausch Health US, LLC$1K
Galderma Laboratories, L.p.$620
Arcutis Biotherapeutics, Inc.$518
plus $3K from 25 others

What the payments were for

Consulting fees$2,72026%
Speaking & faculty fees$1131%
Food & beverage$7,44171%
Education$1662%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Incyte Corporation	39	$1,980
Sun Pharmaceutical Industries Inc.	40	$1,448
Dermavant Sciences, Inc.	31	$1,388
Ortho Dermatologics, A Division Of Bausch Health US, LLC	15	$1,297
Galderma Laboratories, L.p.	25	$620
Arcutis Biotherapeutics, Inc.	5	$518
Pfizer	7	$284
Revance Therapeutics, Inc.	2	$229
LEO Pharma Inc.	4	$227
Mayne Pharma Commercial LLC	8	$211
Sanofi	4	$198
EPI Health, LLC	4	$181
AbbVie	2	$178
VYNE Pharmaceuticals Inc.	2	$174
Almirall LLC	8	$167
Arthrex	2	$145
Journey Medical Corporation	2	$140
Regeneron Healthcare Solutions, Inc.	7	$140
Stemline Therapeutics Inc.	1	$127
Biofrontera Inc.	2	$119
Merz North America, Inc.	2	$103
Sanofi-aventis U.S. LLC	1	$99
Organon	9	$96
Lilly USA, LLC	3	$89
Sebela Pharmaceuticals Inc.	5	$81
Amgen	2	$48
Novartis	2	$43
Verrica Pharmaceuticals Inc.	2	$42
LNHC, Inc	2	$40
Mission Pharmacal Company	1	$14
E.r. Squibb & Sons, L.L.C.	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Cabtreo$900
Winlevi$800
VTAMA$514
ZORYVE$494
DUPIXENT$207
ZILXI$150
DAXXIFY$143
AKLIEF$125
ANZUPGO$120
WYNZORA$113
ARAZLO$110
Skyrizi$106
NEMLUVIO$105
ALTRENO$105
AMELUZ$102
BF-RhodoLED$102
XEPI$102
OPZELURA$101

How this compares

$10,440 in reported general payments places this provider in the 95th percentile of 4,098 physician assistant providers in Ohio.

See all physician assistant providers in Ohio →

Medicare billing

Part B allowed, 2024

$428,003

Medicare patients

1,269

Services billed

6,493

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Clobetasol Propionate	133	$6,541
Ketoconazole	214	$3,067
CiclopiroxCiclopirox Olamine	129	$2,651
Metronidazole	17	$2,124
Triamcinolone Acetonide	148	$1,503
Clindamycin-Benzoyl PeroxideClindamycin Phos/Benzoyl Perox	14	$1,116
Doxycycline Hyclate	57	$914
Clindamycin Phosphate	18	$731
Betamethasone Dipropionate	13	$584
ValacyclovirValacyclovir Hcl	54	$480
Mupirocin	71	$455
Minoxidil	29	$445
Hydrocortisone	36	$359

Paid to pharmacies, not to this prescriber.

Other physician assistant in Cincinnati

Steven WurzelbacherCincinnati$309K
Alan OdonnellCincinnati$71K
Melissa DoveCincinnati$41K
Emily AnkromDayton$192K
Amanda MaggartWorthington$164K
Megan SevillaMayfield Heights$132K
Erin StrculaBelpre$106K
Natalie WalkupSylvania$105K
Sarah LaubNew Albany$100K
Jessica RhominskiCanal Winchester$78K

See the full list for Ohio →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →